Literature DB >> 24360928

Prevalence of clinically recognized alcohol and other substance use disorders among VA outpatients with unhealthy alcohol use identified by routine alcohol screening.

Emily C Williams1, Anna D Rubinsky2, Gwen T Lapham3, Laura J Chavez4, Stacey E Rittmueller5, Eric J Hawkins6, Joel R Grossbard7, Daniel R Kivlahan6, Katharine A Bradley8.   

Abstract

OBJECTIVE: The purpose of routine alcohol screening is to identify patients who may benefit from brief intervention, but patients who also have alcohol and other substance use disorders (AUD/SUD) likely require more intensive interventions. This study sought to determine the prevalence of clinically documented AUD/SUD among VA outpatients with unhealthy alcohol use identified by routine screening.
METHODS: VA patients 18-90 years who screened positive for unhealthy alcohol use (AUDIT-C ≥3 women; ≥4 men) and were randomly selected for quality improvement standardized medical record review (6/06-6/10) were included. Gender-stratified prevalences of clinically documented AUD/SUD (diagnosis of AUD, SUD, or alcohol-specific medical conditions, or VA specialty addictions treatment on the date of or 365 days prior to screening) were estimated and compared across AUDIT-C risk groups, and then repeated across groups further stratified by age.
RESULTS: Among 63,397 eligible patients with unhealthy alcohol use, 25% (n=2109) women and 28% (n=15,199) men had documented AUD/SUD (p<0.001). The prevalence of AUD/SUD increased with increasing AUDIT-C risk, ranging from 13% (95% CI 13-14%) to 82% (79-85%) for women and 12% (11-12%) to 69% (68-71%) for men in the lowest and highest AUDIT-C risk groups, respectively. Patterns were similar across age groups.
CONCLUSIONS: One-quarter of all patients with unhealthy alcohol use, and a majority of those with the highest alcohol screening scores, had clinically recognized AUD/SUD. Healthcare systems implementing evidence-based alcohol-related care should be prepared to offer more intensive interventions and/or effective pharmacotherapies for these patients. Published by Elsevier Ireland Ltd.

Entities:  

Keywords:  Alcohol screening; Alcohol use disorders; Substance use disorders

Mesh:

Year:  2013        PMID: 24360928     DOI: 10.1016/j.drugalcdep.2013.11.016

Source DB:  PubMed          Journal:  Drug Alcohol Depend        ISSN: 0376-8716            Impact factor:   4.492


  13 in total

1.  Hepatitis C eradication with direct-acting anti-virals reduces the risk of variceal bleeding.

Authors:  Andrew M Moon; Pamela K Green; Don C Rockey; Kristin Berry; George N Ioannou
Journal:  Aliment Pharmacol Ther       Date:  2019-11-27       Impact factor: 8.171

2.  Influence of comorbid drug use disorder on receipt of evidence-based treatment for alcohol use disorder among VA patients with alcohol use disorder and Hepatitis C and/or HIV.

Authors:  Madeline C Frost; Theresa E Matson; Judith I Tsui; Emily C Williams
Journal:  Drug Alcohol Depend       Date:  2018-10-30       Impact factor: 4.492

3.  Increased Risk for Hepatocellular Carcinoma Persists Up to 10 Years After HCV Eradication in Patients With Baseline Cirrhosis or High FIB-4 Scores.

Authors:  George N Ioannou; Lauren A Beste; Pamela K Green; Amit G Singal; Elliot B Tapper; Akbar K Waljee; Richard K Sterling; Jordan J Feld; David E Kaplan; Tamar H Taddei; Kristin Berry
Journal:  Gastroenterology       Date:  2019-07-26       Impact factor: 22.682

4.  Correlates of alcohol use disorder pharmacotherapy receipt in medically insured patients.

Authors:  Alexander Rittenberg; Anika L Hines; Anika A H Alvanzo; Geetanjali Chander
Journal:  Drug Alcohol Depend       Date:  2020-07-15       Impact factor: 4.492

5.  Practical Assessment of Alcohol Use Disorder in Routine Primary Care: Performance of an Alcohol Symptom Checklist.

Authors:  Kevin A Hallgren; Theresa E Matson; Malia Oliver; Katie Witkiewitz; Jennifer F Bobb; Amy K Lee; Ryan M Caldeiro; Daniel Kivlahan; Katharine A Bradley
Journal:  J Gen Intern Med       Date:  2021-08-16       Impact factor: 6.473

6.  Patterns of alcohol use and associated characteristics and HIV-related outcomes among a sample of African-American women living with HIV.

Authors:  Lauren Lipira; Deepa Rao; Paul E Nevin; Christopher G Kemp; Susan E Cohn; Janet M Turan; Jane M Simoni; Michele P Andrasik; Audrey L French; Joseph M Unger; Patrick Heagerty; Emily C Williams
Journal:  Drug Alcohol Depend       Date:  2019-11-20       Impact factor: 4.492

7.  Longitudinal Drinking Patterns and Their Clinical Correlates in Million Veteran Program Participants.

Authors:  Rachel Vickers Smith; Henry R Kranzler; Amy C Justice; Janet P Tate
Journal:  Alcohol Clin Exp Res       Date:  2019-02-03       Impact factor: 3.455

8.  Practical assessment of DSM-5 alcohol use disorder criteria in routine care: High test-retest reliability of an Alcohol Symptom Checklist.

Authors:  Kevin A Hallgren; Theresa E Matson; Malia Oliver; Ryan M Caldeiro; Daniel R Kivlahan; Katharine A Bradley
Journal:  Alcohol Clin Exp Res       Date:  2022-03       Impact factor: 3.455

9.  Impact of Obeticholic acid Exposure on Decompensation and Mortality in Primary Biliary Cholangitis and Cirrhosis.

Authors:  Binu V John; Kaley Schwartz; Cynthia Levy; Bassam Dahman; Yangyang Deng; Paul Martin; Tamar H Taddei; David E Kaplan
Journal:  Hepatol Commun       Date:  2021-05-06

10.  Evaluation Within 30 Days of Referral for Liver Transplantation is Associated with Reduced Mortality: A Multicenter Analysis of Patients Referred Within the VA Health System.

Authors:  Binu V John; Kaley Schwartz; Andrew R Scheinberg; Bassam Dahman; Seth Spector; Yangyang Deng; David Goldberg; Paul Martin; Tamar H Taddei; David E Kaplan
Journal:  Transplantation       Date:  2022-01-01       Impact factor: 5.385

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.